Metraipolis › archive › dc_54b3e2ecbb6e

Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety — Europe PMC PMID:41541752

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41541752
DOI
10.1155/ije/9495296
License (as archived)
solo-consultazione
Archived
2026-11-06T19:31:49.636Z
SHA-256 of the archived text
f8dda6c7d1dc4c5494a9677b3aa816bd953f14aeb974e4a061f1c2203cc5de41
Stable URL of this page
https://metraipolis.com/documento/dc_54b3e2ecbb6e

How to cite

Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety — Europe PMC PMID:41541752 — Europe PMC (en), https://europepmc.org/article/MED/41541752 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54b3e2ecbb6e (Metraipolis archive dc_54b3e2ecbb6e, sha256 f8dda6c7d1dc4c5494a9677b3aa816bd953f14aeb974e4a061f1c2203cc5de41)
BibTeX
@misc{dc54b3e2ecbb6e,
  title = {Early Low-Dose Rituximab for Mild-to-Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety — Europe PMC PMID:41541752},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41541752},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54b3e2ecbb6e; sha256 f8dda6c7d1dc4c5494a9677b3aa816bd953f14aeb974e4a061f1c2203cc5de41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41541752. Agents can read the archived copy with the MCP tool read_document.